For rare disease patients in Mainland China, hope of greater access to treatment
Clarivate
MAY 24, 2022
Recent policy and regulatory moves have begun to sketch out a framework for rare disease drug approvals in the country, but obstacles to approvals and patient access remain. The list, designed to serve as a reference point for prioritized drug review and evaluation policies, included 121 rare diseases. [8].
52 
Let's personalize your content